跳至主要内容
临床试验/NCT04081623
NCT04081623终止不适用

Trans-abdominal Fetal Pulse Oximetry: Signal Integrity

Raydiant Oximetry, Inc.1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2019年4月16日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
9
试验地点
1
主要终点
Fetal signal integrity

研究概览

简要总结

This project is set up to advance and integrate the established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters,

详细描述

The investigational device is a non-invasive fetal pulse oximeter that measures fetal arterial pulse signal using safe, noninvasive, transabdominal near-infrared spectroscopy. The optical sensor will obtain fetal pulse oximetry signals. Women will also undergo sonographic evaluation to assess distance from maternal skin to fetal tissue and to confirm fetal presentation and position. There is no change to standard of care procedures for fetal heart rate monitoring. The fetal heart rate that will be monitored with the investigational device will be used for research purposes only. Results will not be used to guide or alter patient management.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women with singleton pregnancies, vertex presentation
  • Age ≥ 18 years
  • Healthy women ≥ 28 weeks gestation undergoing either Non-Stress test (NST) or Biophysical profile (BPP) OR
  • Healthy women ≥ 37 weeks in labor
  • Vertex presentation

排除标准

  • Age <18 years
  • Multiple gestation ( twins, triplets)
  • Presentation other than vertex
  • < 28 weeks of gestation

结局指标

主要结局

Fetal signal integrity

时间窗: During NST, BPP, or active labor

Integrity of the fetal signal relative to background maternal signal and biologic/electronic noise, and related to fetal position, presentation and the depth of the fetus from maternal skin.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验